P3 Health Partners Return on Tangible Equity 2020-2025 | PIII

Current and historical return on tangible equity values for P3 Health Partners (PIII) over the last 10 years. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.
P3 Health Partners Return On Tangible Equity Historical Data
Date TTM Net Income Tangible Equity Return on Tangible Equity
2025-06-30 $-0.15B $-0.49B 29.92%
2025-03-31 $-0.14B $-0.49B 28.74%
2024-12-31 $-0.14B $-0.50B 28.41%
2024-09-30 $-0.10B $-0.47B 21.06%
2024-06-30 $-0.07B $-0.46B 13.93%
2024-03-31 $-0.07B $-0.50B 11.31%
2023-12-31 $-0.06B $-0.53B 8.76%
2023-09-30 $-0.13B $-0.50B 17.85%
2023-06-30 $-0.12B $-0.85B 14.25%
2023-03-31 $-0.27B $-0.73B 28.37%
2022-12-31 $-0.27B $-0.75B 22.01%
2022-09-30 $-0.25B $-1.16B 16.31%
2022-06-30 $-0.27B $-1.14B 21.86%
2022-03-31 $-0.14B $-1.86B 15.20%
2021-12-31 $-0.16B $-1.87B 33.24%
Sector Industry Market Cap Revenue
Medical Medical Information Systems $0.053B $1.500B
P3 Health Partners is a patient-centered and physician-led population health management company. P3 Health Partners, formerly known as Foresight Acquisition Corp., is based in NEW YORK.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $46.128B 58.69
Tempus AI (TEM) United States $13.327B 0.00
Doximity (DOCS) United States $12.012B 53.44
Hims & Hers Health (HIMS) United States $9.936B 81.41
IRhythm Technologies (IRTC) United States $5.355B 0.00
Hinge Health (HNGE) United States $4.369B 0.00
Inspire Medical Systems (INSP) United States $2.710B 39.83
Privia Health (PRVA) United States $2.618B 193.91
Heartflow (HTFL) $2.348B 0.00
Phreesia (PHR) United States $1.711B 0.00
Enovis (ENOV) United States $1.686B 8.91
10x Genomics (TXG) United States $1.631B 0.00
Omnicell (OMCL) United States $1.465B 28.22
Schrodinger (SDGR) United States $1.441B 0.00
Azenta (AZTA) United States $1.368B 59.68
Clover Health Investments (CLOV) United States $1.338B 0.00
Claritev (CTEV) United States $1.131B 0.00
Evolent Health (EVH) United States $1.030B 0.00
Fulgent Genetics (FLGT) United States $0.655B 0.00
Zepp Health (ZEPP) Netherlands $0.580B 0.00
Veradigm (MDRX) United States $0.525B 0.00
Standard BioTools (LAB) United States $0.458B 0.00
Talkspace (TALK) United States $0.456B 136.00
Butterfly Network (BFLY) United States $0.350B 0.00
Carlsmed (CARL) United States $0.342B 0.00
TruBridge (TBRG) United States $0.296B 51.87
Outset Medical (OM) United States $0.243B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.232B 0.00
Nyxoah SA (NYXH) Belgium $0.216B 0.00
Health Catalyst (HCAT) United States $0.215B 0.00
KORU Medical Systems (KRMD) United States $0.190B 0.00
CapsoVision (CV) United States $0.186B 0.00
MDxHealth SA (MDXH) Belgium $0.145B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.121B 0.00
CareCloud (CCLD) United States $0.115B 5.23
American Well (AMWL) United States $0.113B 0.00
EUDA Health Holdings (EUDA) Singapore $0.090B 0.00
Insight Molecular Diagnostics (IMDX) United States $0.071B 0.00
Pulmonx (LUNG) United States $0.062B 0.00
111 (YI) China $0.062B 0.00
HeartBeam (BEAT) United States $0.037B 0.00
Precipio (PRPO) United States $0.023B 0.00
Zhongchao (ZCMD) China $0.023B 0.00
Healthcare Triangle (HCTI) United States $0.016B 0.00
PROFUSA (PFSA) United States $0.015B 0.00
Bullfrog AI Holdings (BFRG) United States $0.012B 0.00
Predictive Oncology (POAI) United States $0.010B 0.00
HeartSciences (HSCS) United States $0.008B 0.00
Strata Skin Sciences (SSKN) United States $0.007B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.006B 0.00
Evaxion - (EVAX) Denmark $0.004B 0.00
Movano (MOVE) United States $0.004B 0.00
MSP Recovery (MSPR) United States $0.004B 0.00
Tivic Health Systems (TIVC) United States $0.003B 0.00